Large consulting firms bring teams. Altio brings seniority. The advisor who scopes your engagement does the work. There is no handoff to a delivery team after the proposal is signed, no junior resources managing your relationship, no methodology built for a different industry applied to yours.
We bring direct operational experience in Life Sciences R&D
Life sciences R&D is a specific domain. Pharmacovigilance operations, clinical systems, regulatory submissions, GxP validation: these are not backgrounds acquired by reading about them. Altio’s practice is built on direct operational experience in these environments, combined with working fluency in modern AI systems and agentic architecture.
The result is an advisor who speaks with equal precision to your Chief Data Officer about model architecture and to your Head of Pharmacovigilance about the operational realities of E2B case processing. That combination is not common. It is why Altio exists.
FOUNDER
Arvind Bellur
Arvind Bellur has spent his career at the intersection of life sciences R&D and technology transformation, across pharmacovigilance operations, clinical platforms, regulatory technology, and AI-enabled operating model design in global pharmaceutical organizations.
He founded Altio Advisory to bring that experience to bear as a focused, senior advisory practice working with a small number of clients at a time. He will tell you what is achievable and what is not. He will be honest about risk, timeline, and organizational readiness.
He has operated in regulated environments long enough to understand that compliance is not a constraint on good AI design. It is part of what good AI design means in this industry.
AI Architect and Researcher
Evren Yucekus-Kissane
Evren Yucekus-Kissane is an AI architect and researcher specializing in the design, development, and deployment of machine learning, generative AI, and advanced analytics platforms.
He joins Altio Advisory with a proven track record of delivering hands-on AI solutions within the R&D environments of global pharmaceutical leaders, including Sanofi and CSL, where he built modern architectures and scalable data pipelines for complex scientific use cases. Bridging industry execution with academic rigor, Evren also founded an artificial intelligence and quantum computing research program at the University of Maryland, where he advanced cutting-edge computing research and mentored the next generation of technology practitioners.
At Altio Advisory, Evren translates high-level business challenges into practical, scalable technical architectures. Like Arvind, he views compliance, transparency, and governance not as barriers to innovation, but as core engineering requirements for building AI systems that deliver lasting enterprise value.
Why boutique matters in this space
AI advisory for life sciences requires rare combinations: deep regulatory domain knowledge, technical fluency in modern AI systems, and operational credibility in environments where errors carry patient safety consequences.
Integrated Expertise
Large firms assemble teams with complementary skills. Boutique advisory integrates them in a single senior mind, one that moves faster, communicates with less translation loss, and takes personal accountability for the advice given.
Focused by Design
Altio Advisory works with a focused client roster. That is by design. It means the quality of attention you receive does not degrade with scale.
Domain Experience
Life Sciences R&D is a specialized domain. Operational experience in pharmacovigilance, clinical systems, regulatory submissions, and GxP validation is the foundation of the advice we provide and the systems we build.